Briacell Therapeutics Corp
BCTX0.755USD
+0.011+1.48%
收盤 08/04, 16:00（美東）報價延遲15分鐘
4.95M總市值
虧損本益比TTM
關於 Briacell Therapeutics Corp 公司
BriaCell Therapeutics Corp. 是一家臨牀階段的生物技術公司，致力於開發新型免疫療法來改變癌症治療。其 3 期主要候選藥物 Bria-IMT 是一種獲得專利的、現成的、基於細胞的靶向免疫療法，可激活患者的免疫系統，專門殺死癌細胞而不會傷害其他細胞。該公司正在推進其 Bria-IMT 靶向免疫療法與免疫檢查點抑制劑 (Retifanlimab) 的聯合治療，以治療轉移性乳腺癌的關鍵 3 期研究。該公司還在開發個性化的現成免疫療法 Bria-OTS 和 Bria-OTS+，這爲開發針對多種癌症的個性化現成免疫療法提供了平臺技術，以及一種可溶性 CD80 蛋白療法，它既可以作爲免疫系統的刺激劑，也可以作爲免疫檢查點抑制劑。其管道還包括 Bria-IMT + CPI、Bria-BRES/BRES+、Bria-PROS+、Bria-LUNG+ 和 Bria-MEL+。
公司簡介
公司代碼BCTX
公司名稱Briacell Therapeutics Corp
上市日期Oct 12, 2006
CEODr. William V. Williams, M.D.
員工數量17
證券類型Ordinary Share
年結日Oct 12
公司地址Suite 300 - Bellevue Centre, 235 -15th Street
城市WEST VANCOUVER
上市交易所NASDAQ Capital Market Consolidated
國家Canada
郵編V7T 2X1
電話16049211810
網址https://briacell.com/
公司代碼BCTX
上市日期Oct 12, 2006
CEODr. William V. Williams, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
+2.10%
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
10.77K
+34.77%
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
1.19K
+22.93%
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
187.00
--
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
-100.00%
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
--
-100.00%
Dr. Jane A. Gross, Ph.D.
Dr. Jane A. Gross, Ph.D.
Independent Director
Independent Director
--
-100.00%
Dr. Miguel A. Lopez-Lago
Dr. Miguel A. Lopez-Lago
Chief Scientific Officer
Chief Scientific Officer
--
-100.00%
名稱
名稱/職務
職務
持股
持股變動
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
+2.10%
Mr. Jamieson Bondarenko
Mr. Jamieson Bondarenko
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
10.77K
+34.77%
Mr. Vaughn C. Embro-pantalony, CPA
Mr. Vaughn C. Embro-pantalony, CPA
Independent Director
Independent Director
1.19K
+22.93%
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
187.00
--
Mr. Martin E. Schmieg, CPA
Mr. Martin E. Schmieg, CPA
Independent Director
Independent Director
--
--
Dr. Rebecca A. Taub, M.D.
Dr. Rebecca A. Taub, M.D.
Independent Director
Independent Director
--
-100.00%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 8月2日 週六
更新時間: 8月2日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Heights Capital Management, Inc.
5.70%
Iroquois Capital Management, LLC
3.19%
L5 Capital Inc.
0.99%
Lynwood Capital Management Inc.
0.61%
3I Management LLC
0.52%
Other
88.99%
持股股東
持股股東
佔比
Heights Capital Management, Inc.
5.70%
Iroquois Capital Management, LLC
3.19%
L5 Capital Inc.
0.99%
Lynwood Capital Management Inc.
0.61%
3I Management LLC
0.52%
Other
88.99%
股東類型
持股股東
佔比
Investment Advisor
5.81%
Hedge Fund
3.19%
Corporation
1.30%
Investment Advisor/Hedge Fund
1.13%
Individual Investor
0.13%
Research Firm
0.03%
Other
88.41%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
65
831.24K
8.14%
-645.33K
2025Q1
68
476.26K
7.27%
-513.92K
2024Q4
65
403.53K
10.88%
-198.25K
2024Q3
64
441.30K
30.40%
+131.88K
2024Q2
63
437.48K
31.09%
+121.43K
2024Q1
62
332.09K
21.52%
-17.16K
2023Q4
67
402.86K
34.69%
+35.57K
2023Q3
74
369.20K
35.11%
-158.11K
2023Q2
84
434.95K
41.59%
-338.84K
2023Q1
83
423.04K
40.96%
-355.97K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Heights Capital Management, Inc.
489.20K
7.46%
+489.20K
--
Apr 24, 2025
L5 Capital Inc.
174.03K
2.65%
+4.50K
+2.65%
Dec 10, 2024
Lynwood Capital Management Inc.
106.52K
1.62%
+1.14K
+1.08%
Mar 31, 2024
3I Management LLC
91.69K
1.4%
-277.31K
-75.15%
Mar 31, 2025
Copia Fund (Cayman) LP
54.56K
0.83%
+54.56K
--
Dec 29, 2023
UBS Financial Services, Inc.
19.07K
0.29%
+16.43K
+622.20%
Mar 31, 2025
Williams (William V)
10.81K
0.16%
+222.00
+2.10%
Dec 09, 2024
Bondarenko (Jamieson)
10.77K
0.16%
+2.78K
+34.77%
Dec 09, 2024
Group One Trading, L.P.
2.92K
0.04%
-1.60K
-35.37%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 03, 2025
Merger
15<1
Jan 03, 2025
Merger
15<1
Jan 03, 2025
Merger
15<1
Jan 03, 2025
Merger
15<1
公告日期
類型
比率
Jan 03, 2025
Merger
15<1
Jan 03, 2025
Merger
15<1
Jan 03, 2025
Merger
15<1
Jan 03, 2025
Merger
15<1
